The advances of post-stroke depression: 2021 update
- PMID: 34052887
- DOI: 10.1007/s00415-021-10597-4
The advances of post-stroke depression: 2021 update
Abstract
Post-stroke depression (PSD) is one of common and serious sequelae of stroke. Approximately, one in three stroke survivors suffered from depression after stroke. It heavily affected functional rehabilitation, which leaded to poor quality of life. What is worse, it is strongly associated with high mortality. In this review, we aimed to derive a comprehensive and integrated understanding of PSD according to recently published papers and previous classic articles. Based on the considerable number of studies, we found that within 2 years incidence of PSD has a range from 11 to 41%. Many factors contribute to the occurrence of PSD, including the history of depression, stroke severity, lesion location, and so on. Currently, the diagnosis of PSD is mainly based on the DSM guidelines and combined with various depression scales. Unfortunately, we lack a unified mechanism to explain PSD which mechanisms now involve dysregulation of hypothalamic-pituitary-adrenal (HPA) axis, increased inflammatory factors, decreased levels of monoamines, glutamate-mediated excitotoxicity, and abnormal neurotrophic response. At present, both pharmacotherapy and psychological therapies are employed in treating PSD. Although great advance has been made by researchers, there are still a lot of issues need to be addressed. Especially, the mechanism of PSD is not completely clear.
Keywords: Complication; Depression; Neuropsychiatric disease; PSD; Stroke.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Post-stroke depression: A 2020 updated review.Gen Hosp Psychiatry. 2020 Sep-Oct;66:70-80. doi: 10.1016/j.genhosppsych.2020.06.011. Epub 2020 Jun 27. Gen Hosp Psychiatry. 2020. PMID: 32717644 Review.
-
The etiology of poststroke-depression: a hypothesis involving HPA axis.Biomed Pharmacother. 2022 Jul;151:113146. doi: 10.1016/j.biopha.2022.113146. Epub 2022 May 26. Biomed Pharmacother. 2022. PMID: 35643064 Review.
-
[Post-stroke depression].Zh Nevrol Psikhiatr Im S S Korsakova. 2006;Suppl 16:73-9. Zh Nevrol Psikhiatr Im S S Korsakova. 2006. PMID: 18196638 Review. Russian.
-
Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression.Mol Neurobiol. 2024 Jan;61(1):132-147. doi: 10.1007/s12035-023-03563-w. Epub 2023 Aug 17. Mol Neurobiol. 2024. PMID: 37592185 Review.
-
Post-stroke depression.Expert Rev Neurother. 2008 Jan;8(1):75-92. doi: 10.1586/14737175.8.1.75. Expert Rev Neurother. 2008. PMID: 18088202 Review.
Cited by
-
Serum Levels and Clinical Significance of NSE, BDNF and CNTF in Patients with Cancer-associated Ischemic Stroke Complicated with Post-stroke Depression.Actas Esp Psiquiatr. 2024 Aug;52(4):474-483. doi: 10.62641/aep.v52i4.1667. Actas Esp Psiquiatr. 2024. PMID: 39129688 Free PMC article.
-
Family functioning and patients' depressive symptoms: comparison in perceived family function between patients who had an acute ischaemic stroke and their primary family caregivers - a cross-sectional study.BMJ Open. 2023 Nov 21;13(11):e068794. doi: 10.1136/bmjopen-2022-068794. BMJ Open. 2023. PMID: 37989357 Free PMC article.
-
The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.Front Psychiatry. 2022 Apr 26;13:871754. doi: 10.3389/fpsyt.2022.871754. eCollection 2022. Front Psychiatry. 2022. PMID: 35558423 Free PMC article. Review.
-
Risk Factors for Depressive Symptoms in Korean Adult Stroke Survivors: The Korea National Health and Nutrition Examination Survey IV-VII (2007-2018).Int J Environ Res Public Health. 2021 Aug 2;18(15):8178. doi: 10.3390/ijerph18158178. Int J Environ Res Public Health. 2021. PMID: 34360469 Free PMC article.
-
Biological, Psychiatric, Psychosocial, and Cognitive Factors of Poststroke Depression.Int J Environ Res Public Health. 2023 Mar 30;20(7):5328. doi: 10.3390/ijerph20075328. Int J Environ Res Public Health. 2023. PMID: 37047944 Free PMC article.
References
-
- Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A (2002) Personality and vulnerability to depression in stroke patients—a 1-year prospective follow-up study. Stroke 33:2391–2395 - PubMed
-
- Aliprandi A, Longoni M, Stanzani L, Tremolizzo L, Vaccaro M, Begni B, Galimberti G, Garofolo R, Ferrarese C (2005) Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab 25:513–519 - PubMed
-
- Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104 - PubMed
-
- Andersen G, Vestergaard K, Riis JO, Lauritzen L (1994) Incidence of poststroke depression during the first year in a large unselected stroke population determined using a valid standardized rating-scale. Acta Psychiatr Scand 90:190–195 - PubMed
-
- Appelros P, Viitanen M (2004) Prevalence and predictors of depression at one year in a Swedish population-based cohort with first-ever stroke. J Stroke Cerebrovasc Dis 13:52–57 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical